Redcare Pharmacy N.V.
SHPPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $719,234 | $709,189 | $717,286 | $675,137 |
| % Growth | 1.4% | -1.1% | 6.2% | – |
| Cost of Goods Sold | $560,336 | $540,442 | $550,000 | $524,685 |
| Gross Profit | $158,898 | $168,747 | $167,286 | $150,452 |
| % Margin | 22.1% | 23.8% | 23.3% | 22.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $24,054 | $24,405 | $23,099 | -$18,832 |
| SG&A Expenses | $161,030 | $169,472 | $176,700 | -$54,488 |
| Sales & Mktg Exp. | $136,976 | $145,067 | $153,601 | -$35,656 |
| Other Operating Expenses | -$48 | -$73 | -$322 | $228,552 |
| Operating Expenses | $160,982 | $169,399 | $176,378 | $174,064 |
| Operating Income | -$2,084 | -$652 | -$9,092 | -$23,612 |
| % Margin | -0.3% | -0.1% | -1.3% | -3.5% |
| Other Income/Exp. Net | -$6,918 | $4,796 | -$3,391 | -$2,884 |
| Pre-Tax Income | -$9,002 | $4,144 | -$12,483 | -$26,496 |
| Tax Expense | -$1,659 | -$4,717 | -$862 | -$218 |
| Net Income | -$7,242 | $9,354 | -$10,817 | -$26,481 |
| % Margin | -1% | 1.3% | -1.5% | -3.9% |
| EPS | -0.36 | 0.47 | -0.54 | -1.32 |
| % Growth | -176.6% | 187% | 59.1% | – |
| EPS Diluted | -0.36 | 0.47 | -0.54 | -1.32 |
| Weighted Avg Shares Out | 20,105 | 20,105 | 20,105 | 20,118 |
| Weighted Avg Shares Out Dil | 20,105 | 20,105 | 20,105 | 20,118 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,280 | $15,535 | $1,141 | $371 |
| Interest Expense | $8,198 | $10,739 | $4,857 | $4,032 |
| Depreciation & Amortization | $17,194 | $17,243 | $16,830 | $17,726 |
| EBITDA | $16,390 | $32,126 | $9,204 | -$13,110 |
| % Margin | 2.3% | 4.5% | 1.3% | -1.9% |